Results 81 to 90 of about 1,990 (201)

The effect of ocrelizumab on Balo's tumefactive lesion: A case report

open access: yesRadiology Case Reports
Balo's concentric sclerosis (BCS) is a rare subtype of multiple sclerosis. Advanced MRI metrics, such as magnetization transfer ratio (MTR), fractional anisotropy (FA), mean diffusivity (MD), and the ratio of total N-acetylaspartate concentration/total ...
Muhammad Faraz Raghib, MD   +5 more
doaj   +1 more source

Bilateral abducens nerve palsy in an infant case of fulminant acute disseminated encephalomyelitis: a case report [PDF]

open access: yes, 2016
BACKGROUND: Sixth (abducens) nerve palsy (ANP) is far less frequent in children and has not been reported as a sign of acute disseminated encephalomyelitis (ADEM). We present an infant case of ADEM with bilateral abducens nerve palsy (BANP).
Guilian Sun, Zhiliang Yang
core   +1 more source

7 Tesla MRI in Multiple Sclerosis: Insights From Its Use in Clinical Routine

open access: yesEuropean Journal of Neurology, Volume 32, Issue 8, August 2025.
Insights from the impact of 7T MRI in routine clinical care in patients with not yet clearly defined neuro‐inflammatory disorders of the central nervous system or in MS patients with uncertainties during routine clinical care. ABSTRACT Background 7 Tesla (7 T) magnetic resonance imaging (MRI) offers higher spatial resolution and signal‐to‐noise ratio ...
A. León Betancourt   +9 more
wiley   +1 more source

Frequency of cerebrovascular accidents and brain abscess in childrens with tetralogy of fallot Dr. [PDF]

open access: yes, 2015
OBJECTIVE: To determine the frequency of cerebrovascular accidents and brain abscess in children of Tetralogy of Fallot presented with neurological manifestations. PATIENTS AND METHODS: It was a cross-sectional descriptive observational study done at the
Aftab, Sommayya   +2 more
core   +1 more source

Severe tumefactive rebound of multiple sclerosis following fingolimod cessation [PDF]

open access: yesBMJ Case Reports, 2016
Fingolimod is an oral sphingosine-1-phosphate receptor modulator approved for the treatment of active relapsing-remitting multiple sclerosis (RRMS). Recent reports have highlighted the possible risk of rebound disease activity after withdrawal of fingolimod.
Sharfaraz, Salam   +2 more
openaire   +2 more sources

Multiple Sclerosis and Oligodendroglioma: An Exceptional Association

open access: yesCase Reports in Neurological Medicine, 2014
The cooccurrence of multiple sclerosis (MS) and oligodendroglioma is very rare. We present a 43-year-old male patient with the diagnosis of MS lasting for 14 years who developed seizures and right hemiparesis; cerebral MRI revealed an already known ...
Ana Teresa Carvalho   +3 more
doaj   +1 more source

Diagnosis of multiple sclerosis: progress and challenges [PDF]

open access: yes, 2017
The diagnosis of multiple sclerosis (MS) is based on typical neurological symptoms and signs along with evidence of dissemination of central nervous system (CNS) lesions in space and time.
Brownlee, W   +3 more
core   +1 more source

Clinical impact and safety of brain biopsy in unexplained central nervous system disorders: a real‐world cohort study

open access: yesAnnals of Clinical and Translational Neurology, Volume 12, Issue 4, Page 792-804, April 2025.
Abstract Objective A substantial part of central nervous system (CNS) disorders remains unexplained, despite various new and minimally invasive diagnostic techniques. Within this rapidly developing diagnostic field, the precise role of brain biopsy is unknown.
Robin W. van Steenhoven   +14 more
wiley   +1 more source

A case of retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations

open access: yesRadiology Case Reports
Retinal vasculopathy with cerebral leukoencephalopathy (RVCL) is an autosomal dominant disorder caused by mutations in the TREX1 gene, which affects medium and small arteries and veins. Reported in fewer than 50 families worldwide, RVCL typically affects
Musharaf Khan, DO   +4 more
doaj   +1 more source

Letter on “Real‐World Clinical Experience With Serum MOG and AQP4 Antibody Testing by Live Versus Fixed Cell‐Based Assay”

open access: yes
Annals of Clinical and Translational Neurology, Volume 12, Issue 11, Page 2376-2377, November 2025.
Raveena Vij   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy